Acadia Pharmaceuticals Inc Net Income per Employee (ACAD), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Acadia Pharmaceuticals Inc   (NASDAQ: ACAD)
 

Acadia Pharmaceuticals Inc Net Income per Employee

ACAD's Quarterly Results, Trends, Rankings, Statistics
With an income increase of 18.13% in the second quarter 2026, year on year to cumulative value of $380 million, and with 798 employees, Acadia Pharmaceuticals Inc 's income per employee grew on trailing twelve month basis to $ 476,797. The income per employee at Acadia Pharmaceuticals Inc ' was above the company average.
The Healthcare sector has seen employees of 31 other companies achieving higher income per employee. While income per employee total ranking has improved so far to 336, from total ranking in previous quarter at 339.


What is Income per Employee Ratio?





Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ACAD Net Income per Employee (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Net Income Change 18.13 % -80.84 % 90.32 % 119.07 % -20.14 %
Net Income per Employee (TTM) $ 476,797 470,739 489,975 327,286 278,396
ACAD's Total Ranking # 336 # 339 # 0 # 330 # 270
Seq. Net Income Change 766.1 % -98.67 % 281.13 % 169.18 % 40.44 %

ACAD Company Profile >> Back to ACAD Efficiency Comparisons >> Compare ACAD Net Income per Employee to its Competitors

ACAD Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 32
Healthcare Sector # 51
Overall Market # 336

Net Income per Employee Statistics
High Average Low
$ 489,975 $ -134,308 $ -387,812
(Dec 31 2025)   (Mar 31 2017)







Companies with similar Income per Employee for 12 month ending Jun 30 2026, within Healthcare Sector Income per Employee Income 12 month ending Jun 30 2026Number of Employees Jun 30 2026
Krystal Biotech Inc   818,525.42 $ 241.465  Million 295 
The Greater Cannabis Company Inc   740,754.00 $ 0.741  Million 1 
Omeros Corporation  713,291.43 $ 124.826  Million 175 
Prestige Consumer Healthcare Inc   712,757.89 $ 406.272  Million 570 
Amgen Inc   672,538.46 $ 8,743.000  Million 13,000 
Atlantic Coastal Acquisition Corp Ii  670,333.33 $ 2.011  Million 3 
Illumina Inc   644,531.25 $ 825.000  Million 1,280 
Liquidia Corporation  641,694.44 $ 138.606  Million 216 
Harmony Biosciences Holdings inc   618,668.94 $ 181.270  Million 293 
Protagonist Therapeutics inc   616,272.73 $ 81.348  Million 132 
Theravance Biopharma inc   597,866.67 $ 53.808  Million 90 
Vaxart Inc   593,676.92 $ 38.589  Million 65 
Glucotrack Inc   554,600.00 $ 8.319  Million 15 
Eli Lilly And Company  534,224.00 $ 26,711.200  Million 50,000 
Silexion Therapeutics Corp  489,714.29 $ 6.856  Million 14 
Sanuwave Health Inc   477,290.91 $ 26.251  Million 55 
Acadia Pharmaceuticals Inc   476,796.99 $ 380.484  Million 798 
Biolife Solutions Inc   374,070.97 $ 57.981  Million 155 
Indivior Pharmaceuticals Inc   356,000.00 $ 356.000  Million 1,000 
Neurocrine Biosciences Inc   352,750.00 $ 705.500  Million 2,000 
Jazz Pharmaceuticals Plc  325,523.53 $ 940.763  Million 2,890 
Alnylam Pharmaceuticals Inc   323,195.20 $ 807.988  Million 2,500 
Spero Therapeutics Inc   295,320.00 $ 7.383  Million 25 
Eton Pharmaceuticals Inc   288,363.64 $ 12.688  Million 44 
Bristol myers Squibb Company  285,353.85 $ 9,274.000  Million 32,500 
Regeneron Pharmaceuticals Inc   280,902.01 $ 4,328.700  Million 15,410 
Adma Biologics Inc   261,139.10 $ 168.957  Million 647 
Siga Technologies Inc  247,213.16 $ 12.113  Million 49 
Interpace Biosciences Inc   239,676.47 $ 24.447  Million 102 


Date modified: 2026-09-11T09:45:24+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.